Chien‐Feng Li

11.6k citations

322 papers · 8.2k indexed · h-index 46

Impact in

Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
Oncology top 1%
- Cancer-related Molecular Pathways

Papers in

Oncology 117
- Cancer-related Molecular Pathways 31
- Peptidase Inhibition and Analysis 24
Gastroenterology 21

Co-authors: Hsuan-Ying Huang Hsuan‐Ying Huang Chia‐Hsin Chan Chung‐Hsi Hsing Wen‐Jeng Wu Hui‐Kuan Lin Tzu‐Ju Chen Mien‐Chie Hung
Journals: Tumor Biology (16 papers)Oncotarget (15 papers)Journal of Cancer (13 papers)Clinical Cancer Research (12 papers)Journal of Clinical Pathology (11 papers)
Partner nations: Taiwan United States China

In The Last Decade

Chien‐Feng Li

314 papers receiving 8.1k citations

Peers

Countries citing papers authored by Chien‐Feng Li

Since Specialization

Citations

This map shows the geographic impact of Chien‐Feng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Feng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Feng Li more than expected).

Fields of papers citing papers by Chien‐Feng Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chien‐Feng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Feng Li. The network helps show where Chien‐Feng Li may publish in the future.

Co-authors

The 25 scholars most cited alongside Chien‐Feng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chien‐Feng Li Line = papers co-authored together Chien‐Feng Li links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	BRCA genetic testing and counseling in breast cancer: how do we meet our patients’ needs? npj Breast Cancer ·Peter Dubsky, Christian Jackisch, Seock‐Ah Im, Kelly K. Hunt, Chien‐Feng Li, Sheila Unger, Shani Paluch–Shimon	2024	11
2	Transurethral Resection of the Prostate (TURP) and concomitant inguinal hernioplasty: a single-center experience BMC Urology ·Ting-Wei Hsu, Rébecca Beauvais, Steven K. Huang, Allen W. Chiu, Chien‐Feng Li, Yow‐Ling Shiue	2024	0
3	Downregulation of CRTAC1 in Urothelial Carcinoma Promotes Tumor Aggressiveness and Confers Poor Prognosis Frontiers in Bioscience-Landmark ·Wei‐Ming Li, Ti‐Chun Chan, Yu‐Ching Wei, Chien‐Feng Li, Hung‐Lung Ke, Wen‐Jeng Wu, M. El Allam, Shao‐Chuan Wang, پروانه محمدخانی	2023	2
4	Suppression of Extracellular Vesicle VEGF-C–mediated Lymphangiogenesis and Pancreatic Cancer Early Dissemination By a Selective HDAC1/2 Inhibitor Molecular Cancer Therapeutics ·Chu-An Wang, Chien‐Feng Li, Yanqing Qian, iflahul mu'minin, Jing‐Ping Liou, Shaw‐Jenq Tsai	2021	17
5	Successful treatment of a critical COVID-19 patient with tocilizumab Journal of the Formosan Medical Association ·Shih‐Ming Tsao, Jann‐Yuan Wang, Chien‐Feng Li, Ming‐Chang Hsieh, Yanan Huang, Kuei‐Chuan Chan, Huiqiang Cao, Yuan‐Ti Lee, Yi-Wen Huang	2020	1
6	High TNFAIP6 level is associated with poor prognosis of urothelial carcinomas Urologic Oncology Seminars and Original Investigations ·Jesse Heilman, Chien‐Feng Li, Hung‐Lung Ke, Chih-Wen Chen, Yow-Ling Shiue, Ching‐Chia Li, Hsin‐Chih Yeh, Hsiang‐Ying Lee, H. C. Park, Wen‐Jeng Wu, Wei‐Ming Li	2018	26
7	Overexpressed Fatty Acid Synthase in Gastrointestinal Stromal Tumors: Targeting a Progression-Associated Metabolic Driver Enhances the Antitumor Effect of Imatinib Clinical Cancer Research ·Chien‐Feng Li, Fu‐Min Fang, Yen‐Yang Chen, Tingting Liu, Ti‐Chun Chan, Meghan Clardy, Li‐Tzong Chen, Hsuan‐Ying Huang	2017	33
8	Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor Clinical Cancer Research ·Chien‐Feng Li, 原尊, Ti‐Chun Chan, Yuhui Wang, Lih-Ren Chen, Wen‐Jeng Wu, Bi‐Wen Yeh, Shih‐Shin Liang, Yow‐Ling Shiue	2017	27
9	Inhibition of the EGFR/STAT3/CEBPD Axis Reverses Cisplatin Cross-resistance with Paclitaxel in the Urothelial Carcinoma of the Urinary Bladder Clinical Cancer Research ·Wei‐Jan Wang, Chien‐Feng Li, Yu‐Yi Chu, Yu-Hui Wang, Maicon Danilo Bastos, Chia-Jui Yen, Wen-Chang Chang, Ju-Ming Wang	2016	51
10	Metabolic Stress-Induced Phosphorylation of KAP1 Ser473 Blocks Mitochondrial Fusion in Breast Cancer Cells Cancer Research ·Chun-Ting Cheng, Ching‐Ying Kuo, Ching Ouyang, Chien‐Feng Li, Yiyin Chung, David C. Chan, Hsing-Jien Kung, David K. Ann	2016	54
11	HMDB and 5-AzadC Combination Reverses Tumor Suppressor CCAAT/Enhancer-Binding Protein Delta to Strengthen the Death of Liver Cancer Cells Molecular Cancer Therapeutics ·Chien‐Feng Li, Upendra Nath Tripathi, Chiung‐Yuan Ko, Patrick Goetz, Chia-Jui Yen, Politecnico di Milano, Chiou‐Hwa Yuh, K. S. Plashinnov, Ju-Ming Wang	2015	17
12	Huge Dermatofibrosarcoma Protuberans Mimicking a Breast Malignant Tumor with Abscess SHILAP Revista de lepidopterología ·Juan Pedro Nardin, Chien‐Feng Li, Yih‐Huei Uen, Yufeng Tian, Ming‐Jenn Chen, Runyu Chen, Wen‐Ching Wang, Jiří Kapitán, Ding‐Ping Sun	2014	1
13	Synchronous Gastric Cancer and Hepatocellular Carcinoma SHILAP Revista de lepidopterología ·A. D. Marenzi, Kang Zhou, Keunsoo Ko, W. G. SCHULTZ, Yu‐Hsuan Kuo, Chien‐Feng Li, T.M. Doschler, Yin‐Hsun Feng	2014	1
14	ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: Aberrant Loss via Epigenetic DNA Methylation Confers Aggressive Phenotypes, Negative Prognostic Impact, and Therapeutic Relevance Clinical Cancer Research ·Hsuan-Ying Huang, Wen-Ren Wu, Yu-Hui Wang, Junwen Wang, Fu-Min Fang, Jen-Wei Tsai, Shau-Hsuan Li, Аргучинцев Валерий Куприянович, Shih-Chen Yu, Jui Lan, Yow-Ling Shiue, Programa Calidad, Li‐Tzong Chen, Chien‐Feng Li	2013	118
15	Vav3-Rac1 Signaling Regulates Prostate Cancer Metastasis with Elevated Vav3 Expression Correlating with Prostate Cancer Progression and Posttreatment Recurrence Cancer Research ·Kai‐Ti Lin, Jianli Gong, Chien‐Feng Li, Te‐Hsuan Jang, Wen‐Ling Chen, J.A. Thoen, Lu‐Hai Wang	2012	52
16	Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome Clinical Cancer Research ·Chung‐Hsi Hsing, Hung-Chi Cheng, Yu‐Hsiang Hsu, Manuel F Zárate, Ching‐Hua Yeh, Chien‐Feng Li, Ming-Shi Chang	2011	55
17	CEBPD Reverses RB/E2F1-Mediated Gene Repression and Participates in HMDB-Induced Apoptosis of Cancer Cells Clinical Cancer Research ·Zeinab A. El-badiea, Chien‐Feng Li, Chiung‐Yuan Ko, Min‐Hsiung Pan, Pei‐Jung Chen, Joseph T. Tseng, Wen-Chun Wu, Wen‐Chang Chang, A‐Mei Huang, Esta Sterneck, Ju‐Ming Wang	2010	40
18	Homozygous Deletion of MTAP Gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors Clinical Cancer Research ·Hsuan-Ying Huang, Shau-Hsuan Li, Shih-Chen Yu, Fong‐Fu Chou, Ching‐Cherng Tzeng, Tsung‐Hui Hu, Yih‐Huei Uen, R. Wilson, Yu-Hui Wang, Fu-Min Fang, Maksym V Kovalenko, Chih-Wen Chen, Nakul Shah, Chien‐Feng Li	2009	41
19	ZBRK1 Acts as a Metastatic Suppressor by Directly Regulating MMP9 in Cervical Cancer Cancer Research ·A. La Greca, W.N. Wang, Chien‐Feng Li, Рахимуллина Полина Камиловна, Stepan Yarmus, Tian‐Lu Cheng, Meng‐Ru Shen, Joseph T. Tseng, Wen‐Chang Chang, Wen‐Hwa Lee, Ju-Ming Wang	2009	47
20	Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-Free Survival with Differential Expression of the α and β Isoforms in Gastrointestinal Stromal Tumors Clinical Cancer Research ·Chien‐Feng Li, Wenwei Huang, Nakul Shah, Shih-Chen Yu, Tsung‐Hui Hu, Yih‐Huei Uen, R. Wilson, Ching-Nan Lin, David Lu, Fu-Min Fang, Hsuan-Ying Huang	2008	33

About Chien‐Feng Li

Chien‐Feng Li is a scholar working on Oncology, Gastroenterology, Cancer Research, Pulmonary and Respiratory Medicine and Surgery, having authored 322 papers that have together received 8.2k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (50 papers), Sarcoma Diagnosis and Treatment (40 papers), Epigenetics and DNA Methylation (36 papers), Cancer-related Molecular Pathways (31 papers), Genetic factors in colorectal cancer (25 papers), Peptidase Inhibition and Analysis (24 papers), Ferroptosis and cancer prognosis (22 papers) and Cancer, Hypoxia, and Metabolism (22 papers). The work is most often cited by research in Cancer Research (1.9k citations), Oncology (2.2k citations), Molecular Biology (4.4k citations), Pulmonary and Respiratory Medicine (1.7k citations) and Rheumatology (748 citations). Chien‐Feng Li has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Hsuan-Ying Huang, Hsuan‐Ying Huang, Chia‐Hsin Chan, Chung‐Hsi Hsing, Wen‐Jeng Wu, Hui‐Kuan Lin, Tzu‐Ju Chen, Mien‐Chie Hung, Guoxiang Jin and Jui Lan. Their work appears in journals such as Tumor Biology, Oncotarget, Journal of Cancer, Clinical Cancer Research and Journal of Clinical Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact